MPLT Earnings & Financial Statements
MapLight Therapeutics, Inc.
$8.83
-$0.32(-3.50%)
11
Overall
--
Value
9
Tech
13
Quality
Market Cap
$571.95M
Volume
495.36K
52W Range
$8.70 - $40.43
Target Price
$27.15
MPLT earnings and financial statements: MapLight Therapeutics, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
MPLT Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Operating income | -$169.08M | -$82.95M | -$57.28M | -$31.25M |
| EBITDA | -$160.55M | -$78.62M | -$57.13M | -$31.03M |
| Net income | -$161.15M | -$77.58M | -$57.68M | -$31.61M |
| EPS (diluted) | $-18.56 | $-105.38 | $-5.03 | $-3.21 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total assets | $479.51M | $136.92M | $91.41M | $39.39M |
| Total liabilities | $21.14M | $105.55M | $103.96M | $102.35M |
| Shareholders’ equity | $458.37M | $31.36M | -$12.55M | -$62.96M |
| Cash and equivalents | $46.73M | $38.25M | $79.77M | $27.66M |
| Long-term debt | $4.91M | $5.80M | $5.43M | $5.92M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Operating cash flow | -$138.14M | -$78.81M | -$52.01M | -$26.58M |
| Capital expenditure | -$473.0K | - | - | - |
| Free cash flow | -$138.61M | -$79.58M | -$52.47M | -$27.32M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | MPLT | $8.83 | -3.5% | 495.36K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get MapLight Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW